Medicare Advantage Beneficiaries with Cancer: Impact of Narrow Networks
Overview
This report examines the disenrollment patterns of Medicare Advantage beneficiaries with newly diagnosed cancer, particularly focusing on those in narrow hospital networks. Findings indicate that beneficiaries in non-employer-sponsored plans are more likely to switch plans post-diagnosis.
Background
The Medicare Advantage (MA) program has seen significant growth, surpassing traditional Medicare enrollment for the first time in 2023. Understanding the dynamics of MA plans, especially for vulnerable populations like cancer patients, is crucial.
Data Highlights
No numerical data provided in the source material.
Key Findings
25% of beneficiaries with non-employer-sponsored MA plans switched plans after a cancer diagnosis.
6.5% of beneficiaries with employer-sponsored MA plans switched plans post-diagnosis.
Nearly half of MA beneficiaries were enrolled in plans with fewer than 25% of local cancer hospitals.
Black beneficiaries and those dually eligible for Medicare and Medicaid were disproportionately enrolled in narrow-network plans.
High switching rates in non-employer-sponsored plans suggest dissatisfaction.
Clinical Implications
Healthcare providers should be aware of the challenges faced by Medicare Advantage beneficiaries with cancer.
Conclusion
The findings highlight issues related to network restrictions in Medicare Advantage plans for cancer patients.
